Hepatitis B: 'Sleep timer' for immune cells discovered

byTechnical University MunichA virus-specific T cell (blue) in the vascular system of a liver with chronic hepatitis B virus infection. Credit: Percy A. Knolle / TUMIn chronic hepatitis B, the l

Updated on: July 15,2024

Hepatitis B: 'Sleep timer' for immune cells discovered

byTechnical University MunichA virus-specific T cell (blue) in the vascular system of a liver with chronic hepatitis B virus infection. Credit: Percy A. Knolle / TUMIn chronic hepatitis B, the l

Updated on:July 15,2024

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on: September 10,2024

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on:September 10,2024

Delays in gallstone pancreatitis surgery increase risks

by Medical Journal of AustraliaCredit: Pixabay/CC0 Public DomainThe recommended treatment for mild gallstone pancreatitis in patients aged over 50 years is laparoscopic cholecystectomy, yet over half

Updated on: June 28,2024

Delays in gallstone pancreatitis surgery increase risks

by Medical Journal of AustraliaCredit: Pixabay/CC0 Public DomainThe recommended treatment for mild gallstone pancreatitis in patients aged over 50 years is laparoscopic cholecystectomy, yet over half

Updated on:June 28,2024

Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model

by Sichuan International Medical Exchange and Promotion AssociationPrevalence of minimal hepatic encephalopathy (MHE) in different groups of patients with cirrhosis. Credit:MedComm(2024).

Updated on: August 01,2024

Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model

by Sichuan International Medical Exchange and Promotion AssociationPrevalence of minimal hepatic encephalopathy (MHE) in different groups of patients with cirrhosis. Credit:MedComm(2024).

Updated on:August 01,2024

Functional imaging shows how intestinal and liver diseases mutually influence each other

by Leibniz InstituteHistological inflammation of intestine improves the liver transplantation-free survival in PSC patients. a) Diagram of the study design for the PSC cohort. b) Kaplan–Meier survival

Updated on: June 17,2024

Functional imaging shows how intestinal and liver diseases mutually influence each other

by Leibniz InstituteHistological inflammation of intestine improves the liver transplantation-free survival in PSC patients. a) Diagram of the study design for the PSC cohort. b) Kaplan–Meier survival

Updated on:June 17,2024

Lack of access to affordable, nutritious food puts those with chronic liver disease at a higher risk of death

by University of Southern CaliforniaCredit: Pixabay/CC0 Public DomainFood insecurity, the limited availability of nutritionally adequate food, is a growing public health concern in the United Sta

Updated on: May 26,2024

Lack of access to affordable, nutritious food puts those with chronic liver disease at a higher risk of death

by University of Southern CaliforniaCredit: Pixabay/CC0 Public DomainFood insecurity, the limited availability of nutritionally adequate food, is a growing public health concern in the United Sta

Updated on:May 26,2024

Fecal transplant trial provides hope for liver disease patients

by King's College LondonCredit: Pixabay/CC0 Public DomainThe UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and f

Updated on: June 20,2024

Fecal transplant trial provides hope for liver disease patients

by King's College LondonCredit: Pixabay/CC0 Public DomainThe UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and f

Updated on:June 20,2024

Universal gut microbiome-derived signature predicts cirrhosis

by University of California - San DiegoIllustration depicts a healthy liver (left) and a liver with cirrhosis. Credit: National Institute of Diabetes and Digestive and Kidney DiseasesNonalcoholic

Updated on: May 28,2024

Universal gut microbiome-derived signature predicts cirrhosis

by University of California - San DiegoIllustration depicts a healthy liver (left) and a liver with cirrhosis. Credit: National Institute of Diabetes and Digestive and Kidney DiseasesNonalcoholic

Updated on:May 28,2024

Surprise discovery redirects efforts for treatment of liver disease

by Walter and Eliza Hall Institute of Medical ResearchGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.040WEHI researchers have revealed that common li

Updated on: June 06,2024

Surprise discovery redirects efforts for treatment of liver disease

by Walter and Eliza Hall Institute of Medical ResearchGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.040WEHI researchers have revealed that common li

Updated on:June 06,2024

New findings on hepatitis C in infants can lead to improved treatments

by Karolinska InstitutetElectron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University.O

Updated on: June 17,2024

New findings on hepatitis C in infants can lead to improved treatments

by Karolinska InstitutetElectron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University.O

Updated on:June 17,2024

Treating liver fibrosis and metabolic dysfunction-associated steatohepatitis: Research identifies novel mechanism

Updated on: April 03,2025

Treating liver fibrosis and metabolic dysfunction-associated steatohepatitis: Research identifies novel mechanism

Updated on:April 03,2025

A drug that lowers blood lipids could treat the world's most common liver disease

byUniversity of BarcelonaCredit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.117067The University of Barcelona has led a study that suggests using the drug kno

Updated on: July 11,2024

A drug that lowers blood lipids could treat the world's most common liver disease

byUniversity of BarcelonaCredit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.117067The University of Barcelona has led a study that suggests using the drug kno

Updated on:July 11,2024